Collection 圖書 [5/7] 會議論文/會議摘要 [25/32] 期刊論文 [158/158] Siblings MARK LAWRENCE WAHLQVIST(2008-2012) [138/140] 吳易謙 [54/55] 吳秀英 [10/10] 廖本揚 [39/39] 廖玉潔 [63/65] 張新儀 [245/268] 李孟智 [51/54] 李蘭 [28/28] 林培生 [25/25] 林煜軒 [47/47] 林肇堂 [35/35] 梁賡義 [15/15] 江博煌 [72/78] 溫啟邦(2001-2010) [177/188] 潘文涵 [110/115] 熊昭 [369/379] 莊淑鈞 [43/44] 莊紹源 [162/168] 蔡慧如 [162/165] 蔡憶文(1999-2010) [34/34] 藍祚運(2003-2011) [22/23] 許志成 [385/393] 邱亞文(2005-2013) [63/99] 邱弘毅 [49/49] 邱燕楓 [82/82] 郭耿南(2003-2010) [89/105] 鄒小蕙 [101/105] 鍾仁華 [85/86] 陳主智 [61/61] 陳慶餘(2006-2010) [70/70] 陳美惠 [32/32] 陳豐奇 [53/55] 陳麗光 [106/106] 黃國晉 [15/15] 丘政民(2000-2004) [8/8] 其他 [238/244] 劉仁沛(1998-2002) [64/65] 姚姿君(1999-2002) [3/3] 戴東原(2003-2005) [21/22] 李明亮(2003-2007) [6/6] 林仲彥(1999-2005) [31/33] 林錦瑜(2002-2003) [5/5] 涂醒哲(2003-2004) [4/4] 石曜堂(1999-2006) [20/24] 蔡碧紋(2004-2006) [3/4] 陳淑媛(2001-2004) [3/3] Community Statistics 近3年內發表的文件:19(9.64%) 含全文筆數:188(95.43%) 文件下載次數統計 下載大於0次:188(100.00%) 下載大於100次:177(94.15%) 檔案下載總次數:94826(1.77%) 最後更新時間: 2024-11-28 13:06 Top Upload Loading... Top Download Loading... Recent Submissions Registry of genetic alterations of ... A statistical method for protocol m... Immune killer cells treatment for p... Survival of advanced/recurrent gast... The clinical characteristics and ma... A phase 1 study of biweekly nab-pac... The registry of genetic alterations... Nivolumab plus ipilimumab (N plus I... Polygenic risk score, environmental... Genome-wide association study of lu...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 21-30 of 197. (20 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2021-09-27	Comment on"Biostatistical considerations when using RWD and RWE in clinical studies for regulatory purposes: A landscape assessment": Is real-world evidence real?	Statistics in Biopharmaceutical Research. 2021 Sep 27;15(1):18-19.
2021-09	A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer	Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
2021-05	High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial	Radiotherapy and Oncology. 2021 May;158:146-154.
2021-05	TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143.
2021-05	A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.
2021-02-05	Tolerance interval testing for assessing accuracy and precision simultaneously	PLoS ONE. 2021 Feb 5;16(2):Article number e0246642.
2021-02	On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes	Contemporary Clinical Trials. 20201 Feb;101:Article number 106244.
2021-01	Use of a two-sided tolerance interval in the design and evaluation of biosimilarity in clinical studies	Pharmaceutical Statistics. 2021 Jan;20(1):175-184.
2020-12-29	Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia	Environment International. 2020 Dec 29;147:Article number 105975.
2020-12-02	A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)	PLoS ONE. 2020 Dec 2;15(12):Article number e0242763.

Showing items 21-30 of 197. (20 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page